169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#902UTILIZATION OF A FASTING-MIMICKING DIET TO REDUCE SENESCENT CELLS AND INFLAMMATION
#903NOVEL METHODS FOR EARLY IDENTIFICATION OF BONE HEALING ABILITY IN INJURED PATIENTS
#904METABOLIC RESCUE OF RETINAL DEGENERATION
#905DIAGNOSIS OF AN AORTIC DISSECTION BY DETECTING A SPECIFIC BIOMARKER IN A BLOOD SAMPLE
#906SEPSIS MANAGEMENT
#907Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
#908Biomarkers for graft-versus-host disease
#909Methods and compositions for evaluation and treatment of renal injury and renal failure based on C-C motif chemokine ligand 14 measurement
#910DIABETES THERAPY TARGETING ABNORMAL STEM CELLS
#911Methods For The Diagnosis Of Fetal Abnormalities
#912RAPID INTRA-CELLULAR ASSAY AND USE OF THE SAME
#913METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#914METHOD FOR ASSAYING LOWER RESPIRATORY TRACT INFECTION OR INFLAMMATION
#915Cyclooxygenase-2 Inhibition for the Treatment of SAA-high Asthma
#916METHODS FOR THE CHARACTERIZATION OF FLUID
#917Methods, Kits and Compositions for Diagnosing and Treating Renal Disease
#918Method of Diagnosing and Treatment Monitoring of Crohn's Disease and Ulcerative Colitis
#919Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#920TESTING AND REPRESENTING SUSPICION OF SEPSIS
#921METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN ALLERGY OR ANAPHYLAXIS
#922NON-INVASIVE ASSAY FOR DETECTING AND MONITORING SYSTEMIC INFLAMMATION
#923METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASE DETECTION AND MANAGEMENT
#924BIOMARKERS FOR THE DIAGNOSIS OF ATRIAL FIBRILLATION CAUSE OF STROKE
#925METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK
#926Multi-Biomarker Prediction Models for Multiple Infection Episodes Following Blunt Trauma
#927METHOD FOR MAKING A FINDING FOR THE FUNCTIONALITY OF AN ANOREXIGENIC SIGNAL PATH FOR A PATIENT
#928Spectroscopic biological material characterization
#929METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS
#930METHODS FOR DIAGNOSING AND TREATING UVEITIS
#931Biomarker For Diagnosing Johne's Disease Comprising Alpha-2-Macroglobulin And Uses Thereof
#932IN VITRO METHOD FOR DETERMINING THE LIKELIHOOD OF OCCURRENCE OF AN ACUTE MICROVASCULAR REJECTION (AMVR) AGAINST A RENAL ALLOGRAFT IN AN INDIVIDUAL
#933COMPOSITIONS AND METHODS OF TREATING THROMBOSIS
#934OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION
#935Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same
#936METHODS AND KITS FOR QUANTITATING RADIATION EXPOSURE
#937Product and methods useful for modulating and evaluating immune responses
#938THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE
#939DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#940HEART FAILURE MARKER
#941METHODS RELATING TO SEPSIS ASSOCIATED ACUTE KIDNEY INJURY
#942BIOMARKERS OF EARLY OSTEOARTHRITIS
#943METHOD FOR ASSESSING POSSIBILITY OF ONSET OR PROGRESSION OF CHRONIC KIDNEY ALLOGRAFT REJECTION AND CHRONIC KIDNEY DISEASE, TEST KIT, AND PHARMACEUTICAL COMPOSITION
#944METHODS AND COMPOSITIONS FOR CHARACTERIZING INFLAMMATORY BOWEL DISEASE
#945METHOD FOR RAPID DETECTION OF DRY EYE SYNDROME
#946Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#947METHOD FOR SELECTING A PATIENT FOR A REPERFUSION THERAPY
#948Methods of obtaining and using electrochemical diagnostic results
#949Metabolite biomarkers for diseases associated with the contact activation system
#950PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#951Compositions and methods for treating heart failure
#952METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#953PROGNOSIS PREDICTION METHOD OF IDIOPATHIC PULMONARY FIBROSIS
#954USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#955Methods and devices for quantitatively estimating syndecan-1
#956Cardiovascular Risk Event Prediction and Uses Thereof
#957USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#958Biomarker for diagnosing rheumatoid arthritis and uses thereof
#959CONFORMATION-SPECIFIC ANTIBODIES THAT BIND NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS
#960COMPOSITIONS AND METHODS FOR DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE
#961BIOMARKERS FOR ASSESSING EXPLANT ORGAN VIABILITY
#962Biomarker for diagnosing depression and uses thereof
#963DODECANE AS EXHALED BIOMARKER FOR EXERCISE-INDUCED ASTHMA IN CHILDREN
#964Methods of Assessing Unbound PCSK9 or Effective PCSK9 Activity
#965METHODS FOR IDENTIFYING AND TREATING URINARY TRACT INFECTIONS
#966CIRCULATING BIOMARKERS OF PRECLINICAL PULMONARY FIBROSIS
#967DEVICE AND METHOD FOR DETECTING INFLAMMATION
#968METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#969METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEDG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEDG
#970Methods of prognosis and treatment
#971METHODS OF MONITORING MUCOSAL HEALING
#972METHODS FOR ASSESSING THE RISK OF DEVELOPING ACTIVE TUBERCULOSIS
#973COMPOSITIONS AND METHODS FOR DETECTING ALLERGEN REACTIVE TH2 CELLS
#974ALLERGY THERAPY
#975ANTIGENIC NEURON SPECIFIC ENOLASE PEPTIDES FOR DIAGNOSING AND TREATING AUTISM
#976NOVEL MOLECULAR TOOLS TO VISUALIZE AND TARGET THE CARDIAC CONDUCTION SYSTEM (CCS)
#977PEPTIDE ANTIGENS AND USES THEREOF
#978CAPTURING TRUNCATED PROTEOFORMS IN EXHALED BREATH FOR DIAGNOSIS AND TREATMENT OF DISEASES
#979Methods of assigning a COVID pathological type based on a cytokine/chemokine panel
#980Assay for Assessing Heart Failure
#981Compositions and Methods for Identifying and Treating Dystonia Disorders
#982HIGH-SENSITIVITY IMMUNOASSAY FOR THE DETECTION OF FRATAXIN IN BIOFLUIDS
#983METHODS AND COMPOSITIONS FOR DETERMINATION OF LIVER FIBROSIS
#984MONITORING GENE THERAPY
#985MARKERS FOR ATRIAL FIBRILLATION (AF)
#986BIOMARKER IN OSTEOPOROSIS INTERVENTION THERAPY BY BONE PEPTIDE, SCREENING METHOD AND USE THEREOF
#987APPLICATIONS OF SERUM S100A8/A9 COMPLEX LEVEL IN PROGNOSIS ASSESSMENT OF ACUTE MYOCARDIAL INFARCTION
#988EXPANDABLE LIVER ORGANOIDS, MEDIA COMPOSITION FOR DIFFERENTIATION THEREOF, AND METHOD FOR PRODUCING LIVER ORGANOIDS USING THE SAME
#989COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM
#990METHOD OF USING DIGITAL TWIN BIOMARKER PROFILES FOR IMPROVED SPORTS TRAINING AND PERFORMANCE, WELLNESS AND HEALTHCARE OUTCOMES
#991Systems and Methods for Machine Learning-based Identification of Acute Kidney Injury in Trauma Surgery and Burned Patients
#992CORRECTING PROTEIN MISFOLDING IN DIABETES
#993Biomarker panel for non-invasive diagnosis of congenital renal dysfunction
#994COMPLIANCE METHOD
#995REAGENT, TEST PAPER, REAGENT KIT, AND TEST PAPER KIT FOR DETECTING SULFHYDRYL COMPOUND, AND PREPARATION METHOD THEREOF
#996METHODS TO DETECT MTBR TAU ISOFORMS AND USE THEREOF
#997CELIAC DISEASE DIAGNOSIS METHOD
#998COMPUTATIONAL SENSING WITH A MULTIPLEXED FLOW ASSAYS FOR HIGH-SENSITIVITY ANALYTE QUANTIFICATION
#999Devices and Methods for Female Health Monitoring
#1000BLOOD BIOMARKERS FOR APPENDICITIS AND DIAGNOSTICS METHODS USING BIOMARKERS
#1001Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use Thereof
#1002BIOMARKERS FOR JOINT AILMENTS AND USES THEREOF
#1003METHODS FOR DETERMINING THE SEVERITY AND PROGNOSIS OF RSV INFECTION
#1004Methods for Predicting Treatment Response in Ulcerative Colitis
#1005Gene Expression Inflammatory Age and Its Uses
#1006DETECTION OF DYSTROGLYCAN
#1007ACOUSTO-THERMAL SHIFT ASSAY FOR LABEL-FREE PROTEIN ANALYSIS
#1008A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION IN PEDIATRIC PATIENTS
#1009MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION
#1010ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS
#1011COMPOSITIONS AND METHODS FOR PREDICTING LUNG FUNCTION DECLINE IN IDIOPATHIC PULMONARY FIBROSIS
#1012Diagnosis and treatment of inflammatory bowel disease
#1013METHOD FOR DIAGNOSING AND TREATING ATHEROSCLEROSIS BY USING NANOVESICLE TARGETING SITE OF CHANGE IN BLOOD FLOW
#1014DRUG TREATMENT AND BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION
#1015KIT AND METHOD FOR COMBINED DETECTION OF PCT AND PRESEPSIN, AND USE THEREOF
#1016METHOD FOR PREDICTING PROGNOSIS FOR CANCER PATIENT, METHOD FOR PREDICTING EFFECTIVENESS OF ANTICANCER THERAPY, AND METHOD FOR SELECTING APPROPRIATE THERAPY FOR CANCER PATIENT
#1017COMPOSITIONS AND METHODS FOR DETECTING SEPSIS
#1018METHODS FOR DETECTING, QUANTIFYING AND MONITORING IMMUNE-CELL MEDIATED CYTOTOXICITY OF CELL POPULATIONS COMPROMISING IMMUNE CELLS AND/OR STEM CELLS
#1019COMPOSITION FOR DETECTING OR MEASURING ANALYTES
#1020PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS
#1021FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTICOAGULANT-INDUCED COAGULOPATHY
#1022Method of Determining Risk for Chronic Stress and Stroke
#1023MASS SPECTROMETRIC ANALYSIS OF BIOMARKERS
#1024Methods and Products for Assessing Lysosomal System Flux
#1025C3/C5 CONVERTASE ASSAYS
#1026EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#1027DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS
#1028ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK) ANTIBODIES, IMMUNOCONJUGATES, AND METHODS OF USE
#1029ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOF
#1030METHOD OF ELEVATING PREDICTION ACCURACY OF GROUPING SUBJECTS WITH SEVERE DENGUE INFECTION
#1031Human Anti-SOD1 Antibodies
#1032Patient Populations Amenable to IL23-Antagonist Therapy
#1033TREATMENT USING CHIMERIC RECEPTOR T CELLS INCORPORATING OPTIMIZED POLYFUNCTIONAL T CELLS
#1034ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF
#1035METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#1036PRESCRIPTION OF REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS
#1037METHODS AND KITS
#1038METHODS OF IDENTIFYING A SUBJECT SUITABLE FOR AN IMMUNO-ONCOLOGY (I-O) THERAPY
#1039BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON RENAL FIBROSIS
#1040Immunological Reagents
#1041CD137 binding fibronectin type III domains
#1042METHODS FOR THE PREDICTION, PROGNOSIS, AND/OR DIAGNOSIS OF AN INFLAMMATORY RESPONSE ASSOCIATED WITH SCHIZOPHRENIA
#1043Biomarkers of fast progression of chronic kidney disease
#1044OPTIMIZED FRAGMENTATION FOR QUANTITATIVE ANALYSIS OF FUCOSYLATED N-GLYCOPROTEINS BY LC-MS-MRM
#1045METHOD OF USING FOLLISTATIN IN TYPE 2 DIABETES RISK PREDICTION
#1046METHOD FOR ASSISTING EVALUATION OF CONDITION OF KIDNEYS, SYSTEM FOR EVALUATING CONDITION OF KIDNEYS, AND PROGRAM FOR EVALUATING CONDITION OF KIDNEYS
#1047ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOF
#1048EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#1049DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY
#1050SCREENING METHOD
#1051BIOMARKER FOR PREDICTING OR CLASSIFYING SEVERITY OF RHEUMATOID ARTHRITIS USING METABOLITE ANALYSIS
#1052In vitro test method for early detection of endometriosis and/or uterine adenomyosis
#1053NON-HLA MARKERS OF TRANSPLANT REJECTION
#1054Blood RNA biomarkers of coronary artery disease
#1055USES OF ANTI-SIRPg ANTIBODIES
#1056NOVEL ALLERGEN
#1057TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
#1058BIOMARKERS FOR PULMONARY EMBOLISM IN EXHALED BREATH CONDENSATE
#1059Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1060Early diagnosis of infections
#1061NOVEL SECRETED ANTIGENS FOR DIAGNOSIS OF ACTIVE BABESIA MICROTI AND BABESIA DUNCANI INFECTION IN HUMANS AND ANIMALs
#1062DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS
#1063IGFBP7 RATIO FOR HFpEF
#1064USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS
#1065DIAGNOSTIC AND PROGNOSTIC METHODS FOR PERIPHERAL ARTERIAL DISEASES, AORTIC STENOSIS, AND OUTCOMES
#1066EYE DISEASE MARKER
#1067METHOD FOR DIAGNOSING ENDOMETRIOSIS, DISEASE STATE MONITORING METHOD, AND KIT
#1068Use of Reagent for Detecting Expression Level of Transferrin in Preparation of Diagnostic Reagent or Kit for Disease Caused by Imbalance of Intestinal Immune Tolerance
#1069MODULATORS OF TELOMERE DISEASE
#1070RECOMBINANT DEAMIDATED GLIADIN POLYPEPTIDE ANTIGEN, RECOMBINANT ANTIGEN-EXPRESSING GENE, RECOMBINANT EXPRESSION VECTOR, AND PREPARATION METHOD AND APPLICATION THEREOF
#1071METHOD OF DETERMINING THE PROBABILITY OF INFLAMMATORY BOWEL DISEASE IN A SUBJECT BEING ULCERATIVE COLITIS OR CROHN'S DISEASE
#1072BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY
#1073MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
#1074LAMA2, PLXDC2 AND MLL4 AS NOVEL BIOMARKERS FOR PREDIABETES AND DIABETES
#1075CYSTIC FIBROSIS URINE TEST
#1076METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS
#1077Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#1078Anti-complement C1s antibodies and uses thereof
#1079ANTI-TRKA ANTIBODIES AND USES THEREOF
#1080Compositions and methods for the removal of biofilms
#1081METHODS AND MATERIALS FOR TREATING CANCER
#1082Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer
#1083INSULIN-LIKE GROWTH FACTOR AXIS PROTEINS AS CIRCULATING PULMONARY ARTERIAL HYPERTENSION BIOMARKERS
#1084ARTERIOSCLEROSIS AND ARTERIOSCLEROSIS-RELATED DISEASE MARKER
#1085OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF
#1086Method useful in tolerance induction therapy and kits therefore
#1087METHOD FOR THE DIAGNOSIS OF MACCE IN PATIENTS WHO UNDERWENT GASTROINTESTINAL SURGERY
#1088KITS, COMPOSITIONS AND METHODS FOR EVALUATING IMMUNE SYSTEM STATUS
#1089Method and reagents for diagnosing Membranous Nephropathy
#1090Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1091METHOD FOR THE DIAGNOSTIC AND/OR PROGNOSTIC ASSESSMENT OF ACUTE-ON-CHRONIC LIVER FAILURE SYNDROME IN PATIENTS WITH LIVER DISORDERS
#1092Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)
#1093Postural Orthostatic Tachycardia Syndrome and CRTH2
#1094METHODS AND COMPOSITIONS FOR DIAGNOSING DEPRESSION
#1095METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITIS
#1096Diagnosis or Prognosis of Postsurgical Adverse Events
#1097BIOMARKERS OF SUBCLINICAL ATHEROSCLEROSIS
#1098Concurrent analysis of multiple analytes
#1099SYNTHETIC MICRORNA MIMICS
#1100METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
#1101Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#1102PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#1103NOVEL AORTIC ANEURYSM MARKER
#1104METHODS FOR IDENTIFYING DIFFERENTIAL HISTONE RETENTION FOR EPIGENETIC ALTERATIONS IN GERMLINE DNA OF ANIMALS
#1105THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA
#1106Treatment of circadian rhythm disorders
#1107COMPOSITIONS AND METHODS FOR DIAGNOSING URINARY TRACT OBSTRUCTION
#1108METHOD OF DETECTING, DETERMINING, AND TREATING HEAT STRESS BASED ON EXPRESSION OF GRP75 IN AVIAN SPECIES
#1109METHOD FOR ASSISTING EVALUATION OF RENAL PATHOLOGICAL CONDITIONS, SYSTEM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS AND PROGRAM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS
#1110MATERIALS AND METHODS FOR IDENTIFYING AND TREATING EOSINOPHILIC DISORDERS
#1111TEST TO ASSESS LIVER DISEASE SEVERITY
#1112DNA REPAIR BLOOD TEST FOR PREDICTING RESPONSE OF LUNG CANCER PATIENTS TO IMMUNOTHERAPY
#1113Compositions, methods and kits for diagnosis of lung cancer
#1114Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#1115Immunological Reagents
#1116GRP78 AND/OR HSP70 INHIBITORS FOR THERAPEUTIC USE
#1117INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE
#1118NOVEL PSMA SPECIFIC BINDING PROTEINS FOR CANCER DIAGNOSIS AND TREATMENT
#1119FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY
#1120Treatment of circadian rhythm disorders
#1121Treatment of circadian rhythm disorders
#1122SYSTEM FOR INSURANCE UNDERWRITING AND POST POLICY ISSUANCE ACTION
#1123DIAGNOSTIC METHOD EMPLOYING HNL
#1124Detection of glucuronidated and 3-bromotyrosine
#1125NLRP3 INFLAMMASOME INHIBITION
#1126METABOLITES AS DIAGNOSTICS FOR AUTISM SPECTRUM DISORDER IN CHILDREN WITH GASTROINTESTINAL SYMPTOMS
#1127DIAGNOSIS OF NON-ALCOHOLIC STEATOHEPATITIS
#1128METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROPHYLAXIS AND TREATMENT OF LYME DISEASE
#1129METHODS FOR TREATING CHOLESTASIS
#1130METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1131COMPOSITIONS AND METHODS FOR DIAGNOSING ACUTE INFECTIOUS PERITONITIS
#1132USE OF NATRIURETIC PEPTIDES TO ASSESS AND TREAT ACUTE KIDNEY INJURY
#1133Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#1134Biomarkers useful in the treatment of subjects having diseases of the eye
#1135Method for detection and quantification of CLN3 protein
#1136A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF DIABETIC RETINOPATHY AND USE THEREOF
#1137A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF AGE-RELATED MACULAR DEGENERATION AND USE THEREOF
#1138IMMUNOASSAY METHOD FOR FREE AIM IN BIOLOGICAL SAMPLE
#1139INTEGRIN ALPHA V BETA 3 TARGETING PROBE FOR DIAGNOSING RETINOCHOROIDAL NEOVASCULAR DISEASES AND PREPARATION METHOD THEREFOR
#1140SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION
#1141METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1142S100A12 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
#1143S100A8 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
#1144PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS
#1145PREVENTION OR TREATMENT OF FIBROTIC DISEASE
#1146TREATMENT OF SYNUCLEINOPATHY AND ANIMAL MODELS OF SYNUCLEINOPATHY
#1147PAPER-BASED LOW-COST MICROFLUIDIC DEVICES FOR AUTOMATIC MULTISTEP PROCESSES
#1148SYSTEMS, DEVICES, AND METHODS FOR DETECTING EARLY SHOCK
#1149Method for the diagnosis and treatment of essential primary hypertension
#1150BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF
#1151METHODS OF DIAGNOSING DISEASE
#1152Methods and devices female health monitoring
#1153IMMUNOASSAY METHOD FOR FREE AIM IN BIOLOGICAL SAMPLE, AND METHOD FOR DETECTING NASH IN SUBJECT
#1154Urine metabolomics based method of detecting renal allograft injury
#1155TREATMENT STRATIFICATION FOR AN EXACERBATION OF INFLAMMATION
#1156KAWASAKI DISEASE ANTIBODIES IDENTIFY HEPACIVIRUS PEPTIDES
#1157COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS
#1158METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1159Methods and systems for detecting usual interstitial pneumonia
#1160METHODS OF TREATING LIVER DISEASES
#116114-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#1162Methods for treating cholestasis
#1163POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP
#1164METHOD
#1165Inter-alpha inhibitor proteins
#1166SENOLYTIC CAR-T CELLS TARGETING UPAR, A CELL SURFACE AND SECRETED SENESCENCE BIOMARKER
#1167METHODS OF DISEASE ACTIVITY PROFILING FOR PERSONALIZED THERAPY MANAGEMENT
#1168Early detection marker for degenerative osteoarthritis with TRIM24-RIP3 axis
#1169TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
#1170METHODS AND ASSAYS FOR IMMUNE PHENOTYPING
#1171Blood biomarkers for appendicitis and diagnostics methods using biomarkers
#1172FUSION PROTEIN AND HIGH-DENSITY LIPOPROTEIN MEASUREMENT KIT USING SAME
#1173SELENIUM BINDING PROTEIN 1 DETECTION FROM BODY FLUIDS FOR DIAGNOSIS OF PERACUTE TISSUE DAMAGE
#1174Methods for assessing mucosal healing in ulcerative colitis disease patients
#1175Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#1176ANALYSIS AND SORTING OF MOTILE CELLS
#1177Antibodies and Methods for the Detection of Cell Death
#1178Lung Cancer Biomarkers and Uses Thereof
#1179AMYLOID PRECURSOR PROTEIN AS A DIAGNOSTIC MARKER FOR BILIARY ATRESIA
#1180TMA-formation inhibitor treatment for elevated TMA-containing compound diseases
#1181GENETIC MARKER FOR HELICOBACTER PYLORIASSOCIATED DISEASE
#1182Protein activity modification
#1183NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF
#1184METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION
#1185COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES
#1186Modulators of airway basal cells for the treatment or prevention of lung diseases
#1187In vitro method for diagnosing central nervous system injury
#1188Biomarkers of vascular disease
#1189COMBINATORIAL TEMPORAL BIOMARKERS AND PRECISION MEDICINES WITH DETECTION AND TREATMENT METHODS FOR USE IN NEURO INJURY, NEURO DISEASE, AND NEURO REPAIR
#1190METHOD FOR ESTIMATING THE EFFECTIVENESS OF A TREATMENT BY AN ANTI-TNF ALPHA AGENT IN A PATIENT SUFFERING FROM RHEUMATOID ARTHRITIS AND HAVING AN INADEQUATE RESPONSE TO AT LEAST ONE BIOTHERAPY
#1191SYSTEN AND METHOD FOR DISCOVERIG NOVEL TARGET PROTEIN AND COMPANION DIAGNOSTIC BIOMARKER THEREFOR
#1192BIOMARKERS
#1193METHOD FOR DIAGNOSING A LIVER DISEASE
#1194GLX-DERIVED MOLECULE DETECTION
#1195IN VITRO METHOD FOR DETECTING AVIAN INTESTINAL DYSBIOSIS
#1196BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS
#1197Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
#1198SELENOPROTEIN P IN HEART FAILURE
#1199Assays for detecting SARS-CoV-2
#1200TISSUE TESTER